About Genomics & Drug Discovery AI
The Genomics & Drug Discovery AI category is part of the AI in Healthcare market map, tracking 17 companies building in this segment. Diagnostics, medical imaging, clinical AI, and remote monitoring transforming patient outcomes and healthcare delivery. Curated by Hartmann Capital's venture research team.
Companies in Genomics & Drug Discovery AI
- Recursion — Public, $510M
- Insilico Medicine — Series E, $400M
- Atomwise — Series C, $174M
- XtalPi — Series D, $784M
- Insitro — Series C, $743M
- BenevolentAI — Public, $362M
- Relay Therapeutics — Public, $717M
- Schrodinger — Public
- Deep Genomics — Series C, $127M
- Zephyr AI — Series A, $111M
- Isomorphic Labs — Alphabet
- Formation Bio — Series D, $472M
- Exscientia — Acquired, $474M
- Absci — Public, $355M
- LILA — Series A, $350M
- Mandolin — Series A, $40M
- Medeloop — Series A, $15.5M
Frequently Asked Questions
- What companies are in the Genomics & Drug Discovery AI category?
- The Genomics & Drug Discovery AI category includes 17 companies: Recursion, Insilico Medicine, Atomwise, XtalPi, Insitro, BenevolentAI, Relay Therapeutics, Schrodinger, Deep Genomics, Zephyr AI, Isomorphic Labs, Formation Bio, Exscientia, Absci, LILA, Mandolin, Medeloop. This is part of the AI in Healthcare market map maintained by Hartmann Capital.
- How many Genomics & Drug Discovery AI startups are tracked?
- Hartmann Capital tracks 17 companies in the Genomics & Drug Discovery AI segment of the AI in Healthcare market map.
- What are the best funded Genomics & Drug Discovery AI companies?
- Top funded companies in Genomics & Drug Discovery AI include XtalPi ($784M), Insitro ($743M), Relay Therapeutics ($717M), Recursion ($510M), Exscientia ($474M). Browse the full list in the AI in Healthcare market map.
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.